MedPath
HSA Approval

LIPOFUNDIN MCT/LCT INFUSION 20%

SIN05658P

LIPOFUNDIN MCT/LCT INFUSION 20%

LIPOFUNDIN MCT/LCT INFUSION 20%

April 8, 1991

B. BRAUN SINGAPORE PTE LTD

B. BRAUN SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantB. BRAUN SINGAPORE PTE LTD
Licence HolderB. BRAUN SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS

Medical Information

B05BA02

fat emulsions

Manufacturer Information

B. Braun Singapore Pte Ltd.

B BRAUN MELSUNGEN AG

Active Ingredients

SOYA-BEAN OIL, REFINED

100.0g/1000ml

Soybean oil

TRIGLYCERIDES, MEDIUM-CHAIN

100.0g/1000ml

GLYCERIN

25 g/1000 ml

Glycerin

EGG PHOSPHOLIPIDS FOR INJECTION

12.00g/1000ml

Egg phospholipids

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

LIPOFUNDIN MCT/LCT INFUSION 20% - HSA Approval | MedPath